Skip to content

Effects of Menthol on Dyspnoea in COPD Patients

Effects of Menthol on Dyspnoea Induced by Exercise in COPD Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03626519
Acronym
MEDiC
Enrollment
63
Registered
2018-08-13
Start date
2019-09-23
Completion date
2021-03-12
Last updated
2021-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Copd, Dyspnea, Lung Diseases

Keywords

COPD, Menthol, Exercise, Dyspnea

Brief summary

Chronic obstructive pulmonary disease (COPD) is characterised by non-reversible bronchial obstruction associated with systemic disorders and comorbid factors. Dyspnoea is a common symptom among patients with Chronic Obstructive pulmonary Disease (COPD). Dyspnea is the primary symptom limiting exercise and daily activities in these patients. It has been reported that breathing cold air could decrease dyspnoea induced by exercise and could improve exercise performance. The aim of this study is to carry out the effect of cooling sensation induced by menthol chewing-gum on dyspnoea and exercise performance among patients with COPD.

Interventions

OTHERTest with Menthol

patients will perform a Six-minute walk test according to American Thoracic Society guidelines

OTHERTest with placebo

patients will perform a Six-minute walk test according to American Thoracic Society guidelines

Sponsors

Groupe Hospitalier du Havre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* a diagnosis of COPD * Dyspnea in daily living (2-4 on the modified medical research council dyspnea scale) * Clinically stable

Exclusion criteria

* exercise contraindication Any musculoskeletal problems, cardiovascular or neurological comorbidities that limits exercise. * exacerbation during the study * Inability to chew or patients with swallowing disorders

Design outcomes

Primary

MeasureTime frameDescription
Change in Dyspnea after each testsThe outcome will be measured before and at the end of the test, the two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.Change in dyspnea using Modified Borg Scale (0 - 10 points) 0=no dyspnea ; 10 = maximal effort

Secondary

MeasureTime frameDescription
Change in inspiratory capacityThe outcome will be measured before and at the end of the test, the two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.Change in inspiratory capacity (Liters) will be measured using a portable spirometer
Change in Cardiac FrequencyData will be continuously collected during every tests. The two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.Change in Cardiac Frequence (bpm) using a pulse oximetry
Change in respiratory rateData will be continuously collected during every tests. The two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.Change in respiratory rate (cycles per minute) will be measured breath-by-breath using a Respiratory Inductive Plethysmography
Change in tidal volumeThe outcome will be measured before and at the end of the test, the two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.Change in tidal volume (Liters) will be measured breath-by-breath using a portable spirometer
Change in 6-min walk distanceThe outcome will be measured at the end of each tests. The two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.Change in 6-min walk distance (meters).
Change in Oxygen SaturationData will be continuously collected during every tests. The two six-minute walk test will perform the same day, separate from 30 minutes minimum for a total time frame of 1 day.Change in Oxygen Saturation (%) using a pulse oximetry

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026